191
Views
0
CrossRef citations to date
0
Altmetric
Articles

FumDSB can alleviate the inflammatory response induced by fumonisin B1 in growing pigs

, , , , & ORCID Icon
Pages 1619-1633 | Received 25 May 2022, Accepted 04 Jul 2022, Published online: 20 Jul 2022
 

Abstract

Fumonisin B1 (FB1) has the highest natural contamination rate among all fumonisin analogs and can inhibit food intake and weight gain of pigs. Under laboratory conditions, carboxylesterase FumDSB has a high FB1 degradation rate and excellent pH and thermal stability. The present study sought to estimate the effects of FumDSB on growing pigs from the perspective of a brain–intestinal axis. Twenty-four growing pigs of similar weight were divided into Control, FB1 (5 mg FB1/kg feed), and FumDSB (5 mg FB1/kg and 0.1% FumDSB in the feed) groups. After 42 days of feeding, hypothalamus and jejunum samples were collected for quantitative real-time fluorescence, western blotting, and immunohistochemistry. The results showed that FB1 consumption can destruct the tissue structure of hypothalamus and jejunum, affect the expression and distribution of several appetite-related neuropeptides and inflammatory cytokines, thereby inducing neuroinflammatory responses and affecting food intake and weight gain. However, these anorexia effects and inflammatory responses are alleviated when FumDSB is added to the feed. In short, FumDSB can alleviate the inflammatory response induced by FB1 in growing pigs.

Acknowledgement

The authors thank our anonymous reviewers and our colleagues from the Animal Nutrition Laboratory for their valuable critiques and suggestions.

Disclosure statement

No potential conflict of interest was reported by the author(s).

Additional information

Funding

This work was supported by the China Agriculture Research System of MOF and MARA [CARS-43-B-1], Shandong Double Tops Program (2019), Taishan Industry Leadership Project [TSCY20190107] and Key Research and Development Project of Shandong Province [2019GNC106007].

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.